Celularity Inc
Develops allogeneic cell therapies and biomaterials from the human placenta.
CELU | US
Overview
Corporate Details
- ISIN(s):
- US1511901050 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 170 PARK AVE, 7932 FLORHAM PARK
- Website:
- https://celularity.com/
- Sector:
- Manufacturing
Description
Celularity Inc. is a clinical and commercial-stage biotechnology company specializing in cellular and regenerative medicine. The company develops and commercializes therapies derived from the postpartum human placenta. Its core focus is on creating off-the-shelf, allogeneic cell therapies, including genetically modified and unmodified Natural Killer (NK) cells, CAR T-cells, and mesenchymal-like adherent stromal cells (MLASCs). These therapeutic programs target a range of conditions, including cancer, immune disorders, and aging-related degenerative diseases. In addition to its clinical pipeline, Celularity markets a suite of commercial placenta-derived biomaterial products. The company leverages the unique biological properties of the placenta to develop accessible treatments for significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Celularity Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Celularity Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Celularity Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
